The federal district court in Los Angeles did not err in granting default judgment and a permanent injunction to United Construction Products, Inc. dba Bison Innovative Products on its patent…
Purchasers of AstraZeneca LP’s heartburn medication Nexium were not entitled to a new trial to their challenge of "reverse payment" agreements between AstraZeneca and Ranbaxy Pharmaceuticals that…
The Patent Trial and Appeal Board properly found during inter partes review (IPR) that two claims of a patent directed to a mechanism for controlling the operation of a downhole drill string were…
Actavis Laboratories UT, Inc. was unable to show that patents licensed to Endo Pharmaceuticals Inc. covering its testosterone gel product Fortesta® were invalid as obvious in light of prior art,…
A district court did not err in dismissing an inventor’s claim that CBS Corporation, its CBS Interactive subsidiary, and "others under the control or direction of an independent contractor" hired by…
In an inter partes review of a patent owned by Wi-Fi One, LLC ("Wi-Fi"), the Patent Trial and Appeal Board’s decision to deny Wi-Fi’s request to conduct discovery into whether Broadcom Corporation’…
A federal district court did not err in finding that a "cow monitoring system" developed by Netherlands-based Agis Automatisering did not infringe the "rumination" and "estrus" patents held by…
The federal district court in Hartford, Connecticut, erred in denying judgment as a matter of law in an action in which a manufacturer of thermal flexographic processors alleged that a former partner…
A federal trial court erroneously concluded that patent defendant Suunto Oy lacked minimum contacts with the State of Delaware to support the assertion of specific personal jurisdiction in a patent…
Masaba Inc. did not infringe five Superior Industries patents that disclosed a conveyor system for drive-over truck dumps and a braced, telescoping support strut, the U.S. Court of Appeals for the…
